214 related articles for article (PubMed ID: 23754128)
1. Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia.
Charles ED; Orloff MI; Nishiuchi E; Marukian S; Rice CM; Dustin LB
Arthritis Rheum; 2013 Sep; 65(9):2430-40. PubMed ID: 23754128
[TBL] [Abstract][Full Text] [Related]
2. The rheumatoid factor response in the etiology of mixed cryoglobulins associated with hepatitis C virus infection.
Sasso EH
Ann Med Interne (Paris); 2000 Feb; 151(1):30-40. PubMed ID: 10761560
[TBL] [Abstract][Full Text] [Related]
3. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia.
Charles ED; Green RM; Marukian S; Talal AH; Lake-Bakaar GV; Jacobson IM; Rice CM; Dustin LB
Blood; 2008 Feb; 111(3):1344-56. PubMed ID: 17942751
[TBL] [Abstract][Full Text] [Related]
4. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line.
Chezar I; Lobel-Lavi L; Steinitz M; Laskov R
Mol Immunol; 2008 Nov; 46(1):80-90. PubMed ID: 18718665
[TBL] [Abstract][Full Text] [Related]
5. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia.
Sansonno D; De Vita S; Iacobelli AR; Cornacchiulo V; Boiocchi M; Dammacco F
J Immunol; 1998 Apr; 160(7):3594-601. PubMed ID: 9531323
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal IgM rheumatoid factor secreted by CD5-negative B cells during mixed cryoglobulinemia. Evidence for somatic mutations and intraclonal diversity of the expressed VH region gene.
Crouzier R; Martin T; Pasquali JL
J Immunol; 1995 Jan; 154(1):413-21. PubMed ID: 7527818
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia.
Fornasieri A; Bernasconi P; Ribero ML; Sinico RA; Fasola M; Zhou J; Portera G; Tagger A; Gibelli A; D'amico G
Clin Exp Immunol; 2000 Dec; 122(3):400-3. PubMed ID: 11122246
[TBL] [Abstract][Full Text] [Related]
8. IgG cryoglobulinemia.
Gulli F; Basile U; Gragnani L; Napodano C; Pocino K; Miele L; Santini SA; Zignego AL; Gasbarrini A; Rapaccini GL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6057-6062. PubMed ID: 30280791
[TBL] [Abstract][Full Text] [Related]
9. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses.
De Re V; De Vita S; Sansonno D; Gasparotto D; Simula MP; Tucci FA; Marzotto A; Fabris M; Gloghini A; Carbone A; Dammacco F; Boiocchi M
Rheumatology (Oxford); 2006 Jun; 45(6):685-93. PubMed ID: 16399842
[TBL] [Abstract][Full Text] [Related]
10. Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.
Dustin LB; Charles ED
Antivir Ther; 2012; 17(7 Pt B):1449-52. PubMed ID: 23322600
[TBL] [Abstract][Full Text] [Related]
11. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.
Agnello V
Springer Semin Immunopathol; 1997; 19(1):111-29. PubMed ID: 9266635
[TBL] [Abstract][Full Text] [Related]
12. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia.
De Re V; De Vita S; Marzotto A; Rupolo M; Gloghini A; Pivetta B; Gasparotto D; Carbone A; Boiocchi M
Blood; 2000 Nov; 96(10):3578-84. PubMed ID: 11071657
[TBL] [Abstract][Full Text] [Related]
13. Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients.
Basile U; Gulli F; Gragnani L; Pocino K; Napodano C; Miele L; Santini SA; Marino M; Zignego AL; Rapaccini GL
Dig Liver Dis; 2018 Sep; 50(9):938-943. PubMed ID: 29709461
[TBL] [Abstract][Full Text] [Related]
14. Cryoglobulinemia.
Morra E
Hematology Am Soc Hematol Educ Program; 2005; ():368-72. PubMed ID: 16304405
[TBL] [Abstract][Full Text] [Related]
15. Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process.
De Re V; De Vita S; Marzotto A; Gloghini A; Pivetta B; Gasparotto D; Cannizzaro R; Carbone A; Boiocchi M
Int J Cancer; 2000 Jul; 87(2):211-6. PubMed ID: 10861476
[TBL] [Abstract][Full Text] [Related]
16. Relationship between rheumatoid factor and the immune response against hepatitis C virus in essential mixed cryoglobulinemia.
Pietrogrande M; Corona M; Milani S; Rosti A; Ramella M; Tordato G
Clin Exp Rheumatol; 1995; 13 Suppl 13():S109-13. PubMed ID: 8730489
[TBL] [Abstract][Full Text] [Related]
17. CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
Terrier B; Nagata S; Ise T; Rosenzwajg M; Pastan I; Klatzmann D; Saadoun D; Cacoub P
Arthritis Rheumatol; 2014 Feb; 66(2):433-43. PubMed ID: 24504816
[TBL] [Abstract][Full Text] [Related]
18. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy.
Dammacco F; Sansonno D; Piccoli C; Racanelli V; D'Amore FP; Lauletta G
Semin Liver Dis; 2000; 20(2):143-57. PubMed ID: 10946420
[TBL] [Abstract][Full Text] [Related]
19. A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cells.
Charles ED; Orloff MI; Dustin LB
J Immunol Methods; 2011 Jan; 363(2):210-20. PubMed ID: 20875420
[TBL] [Abstract][Full Text] [Related]
20. Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21
Del Padre M; Marrapodi R; Minafò YA; Piano Mortari E; Radicchio G; Bocci C; Gragnani L; Camponeschi A; Colantuono S; Stefanini L; Basili S; Carsetti R; Fiorilli M; Casato M; Visentini M
Front Immunol; 2023; 14():1094871. PubMed ID: 36845129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
